Insider track record
OtherAcross 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Halladay Benjamin. Officer active across 1 company, notably Esperion Therapeutics, Inc.. Cumulatively, 9 filings have been logged. Split: 0 buy · 5 sells. Total volume traded: €12k. Activity tracked since 9 December 2022. The latest transaction was disclosed on 17 April 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations9 total
8 shares@ US$0.9640.1% of flowCommon StockSEC:0001628280-25-018566:0
3,535 shares@ US$1.48339.0% of flowCommon StockSEC:0001628280-25-013812:0
238,000 shares0Common StockSEC:0001628280-25-013198:0
11 shares@ US$1.860.2% of flowCommon StockSEC:0001628280-25-006801:0
9 shares@ US$2.2650.2% of flowCommon StockSEC:0001628280-25-002037:0
3,245 shares@ US$2.42460.7% of flowCommon StockSEC:0001628280-24-051875:0
170,000 shares0Common StockSEC:0001628280-24-011488:0
9,200 shares0Common StockSEC:0001628280-23-007968:0
44,000 shares0Common StockSEC:0001104659-22-126269:0